drugset / Trial / NCT06195163

TRAP Study: Testosterone for Androgen Receptor Polymorphism

NCT06195163

Phase 4 Not yet recruiting 100 enrolled Instituto Bernabeu
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).

Timeline

Start
2025-09-30
Primary completion
2026-09-30
Completion
2026-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 10 mg Other

Indications